ImmuneWatch is striving for excellence in its field and recognises the importance of strong strategic collaborations to achieve their goals. We are therefore open to partnerships with key international academic institutions and private companies.
Do you want to work with us?
Early 2023, ImmuneWatch entered into a public-private partnership with Quantoom Biosciences and the University of Antwerp. The goal of this project is to assess if a detailed analysis of the T-cell receptor response can be utilized to inform vaccine design and augment the vaccine development process. It is believed that the proposed methodology could reduce time and expenditures in the preclinical development process of vaccines. As a proof-of-concept, the team has chosen to work on a rabies vaccine candidate.
Business [at] immunewatch.com
Copyright © 2021 ImmuneWatch BV. ImmuneWatch is a registered trademark.
ImmuneWatch BV | BE0774.472.942 | Lange Gasthuisstraat 29-31, 2000, Antwerp, Belgium